You've followed a careful skincare routine, yet your complexion still looks flat, tired or less resilient than it once did. Fine lines may be more visible, makeup may sit unevenly and the skin can feel as though it needs more than surface hydration. That's where a polynucleotides skin treatment can offer a different approach, one focused on supporting skin quality rather than adding volume.
At Skin Revision in Beaconsfield, we assess whether regenerative treatment is appropriate for the skin in front of us, including its sensitivity, pigmentation patterns, texture and overall barrier health. Polynucleotides aren't a miracle solution and they won't replace every injectable or topical routine, but they can be a considered option for clients who want gradual improvements in hydration, elasticity and texture without a filled appearance.
Why Polynucleotides Are Changing How We Approach Skin Ageing
A familiar consultation begins with a client saying that their skin looks tired despite doing everything “right”. They're cleansing consistently, applying moisturiser and protecting their skin from the sun, yet the complexion still appears crepey or dull. Often, the concern isn't a lack of facial volume. It's a decline in the skin's overall quality.
That distinction matters. Dermal fillers replace or add volume, while polynucleotides are used as a regenerative treatment intended to support the skin's repair environment. They're injected into selected areas to encourage a healthier-looking dermis, with changes developing progressively rather than appearing as an immediate alteration in facial shape.
The appeal is understandable. Many clients want skin that looks fresher, firmer and more hydrated, but they don't want a dramatic change in their features. Polynucleotides fit that preference because the intended outcome is improved tissue quality, not cheek enhancement or lip definition.
A different category of injectable
Polynucleotides are commonly discussed as biostimulators. In practical terms, we use them to support the processes involved in skin repair and regeneration. The treatment is particularly relevant when the main issue is fine texture, early laxity, dullness or crepey skin rather than a clear need for structural correction.
We still use other treatments where they're better suited. Botox can soften selected expression lines, dermal fillers can restore volume or definition and Profhilo can provide a hydration-focused injectable option. Microneedling, chemical peels, LED therapy and HydraFacial may also be appropriate depending on the condition of the skin.
Our practical view: polynucleotides work best when we choose them for skin-quality concerns, not when we expect them to behave like a filler.
At Skin Revision, Jacqui Bannister, our multi award-winning paramedical skin therapist with more than 20 years of experience, works alongside Sarra Kourdi, our advanced skin therapist. We use consultation-led planning rather than treating a product as a universal answer. That means considering whether the client needs regeneration, resurfacing, hydration, pigment control, muscle relaxation or volume support.
Understanding How Polynucleotides Work in the Skin
A client may arrive wanting fresher, more resilient skin without extra cheek or lip volume. Polynucleotides suit that request because they are placed into selected skin layers to support repair, rather than to reshape facial contours.
Polynucleotides are highly purified DNA fragments, typically derived from salmon. They do not alter a person's DNA. Within the skin, the material forms part of a regenerative treatment intended to support cellular repair, hydration and dermal function.
From injection to visible change
The treatment develops through several stages:
The product is placed into selected skin layers. We target areas where texture, elasticity or crepiness are relevant, rather than aiming for immediate volume.
The skin receives regenerative signals. Polynucleotides are associated with cellular repair and fibroblast activity. Fibroblasts help produce structural components such as collagen and elastin.
The dermis receives support. The aim is to improve the environment in which skin cells work, including hydration and elasticity.
Visible changes develop gradually. Clients may notice a fresher surface, improved suppleness and smoother-looking texture as the skin responds. The pace varies, so an instant result should not be expected.
The 2025 systematic review described improvements in hydration, elasticity and dermal health, though the authors noted that the evidence quality was low to moderate. The findings included support for cellular repair and collagen synthesis, with improvements in hydration, elasticity and texture reported across the included studies.

Why this isn't a filler result
A filler is chosen to add support, contour or volume in a defined anatomical area. Polynucleotides are better understood as a treatment for the condition and behaviour of the skin, with subtle, progressive results.
That distinction matters for treatment planning. Polynucleotides may suit thin-looking, crepey or tired skin, but they will not replace structural correction where volume loss is the main concern. They are also not a shortcut for every texture or pigment issue, particularly in sensitive skin or darker skin tones, where injection technique, inflammation control and an appropriate wider plan need careful consideration.
Patience matters too. Some clients notice an early improvement in freshness, while more meaningful changes in texture and resilience develop over time. At Skin Revision, follow-up helps us assess the response instead of judging the outcome immediately after injection.
Clinical Benefits and Who Benefits Most
The best candidates often notice changes in fine lines, crepey texture, uneven surface or acne scarring, rather than a need for added contour. A clinical assessment should also consider skin thickness, barrier condition and the specific layer being treated. Polynucleotides are placed within the superficial to mid dermis, where the aim is to support dermal repair and improve how the skin functions over time. Product formulation and concentration vary between protocols, so treatment should be selected according to the area, skin condition and clinical goals.
Where we may see the most value
Fine lines and crepey texture: Treatment may support a smoother, more resilient appearance where skin has become thin-looking or less supple. Changes are usually gradual rather than an immediate smoothing effect.
Loss of elasticity: Polynucleotides can suit clients seeking improved firmness without obvious added volume. They will not provide the lift or contour created by a structural filler.
Acne scarring: They may form part of a broader plan, although established textural scars often need more than one treatment method. Our guide to improving skin texture and scarring explains why treatment selection needs to match the type and depth of scar.
Uneven colour: Polynucleotides may support overall skin quality, but they are not a standalone treatment for melasma or established pigmentation. A carefully managed skincare and treatment programme may be needed.
The evidence is encouraging but limited. A review of the clinical literature reported improvements in wrinkles, texture and elasticity, with generally mild, short-lived side effects. The findings support a considered regenerative approach, not a promise to correct every concern.
Sensitive and darker skin tones need particular care. An open-label cohort study involved 30 Asian participants who received three Polynucleotide HPT injections over six months. It reported significant improvements in skin surface, firmness, pigmentation and radiance. 43% rated themselves “very much improved”, while 56% reported being “satisfied” or “very satisfied” (open-label cohort findings for Asian skin).
These results cannot predict an identical response for every darker or sensitive skin tone. We assess active inflammation, previous reactions, post-inflammatory pigmentation risk, medication, allergies and barrier health before recommending treatment. A cautious plan is usually safer than an aggressive one.
When combination treatment makes sense
Microneedling may help when superficial scarring and texture are the main concerns. LED therapy can support calming and recovery where sensitivity is a priority. Combining procedures is not automatic, since adding treatments does not guarantee a better result.
For reactive skin, we may start with a conservative injectable plan and stabilise the barrier before introducing another procedure. The aim is a tolerable plan that can be maintained and reviewed properly.
Your Treatment Journey at Skin Revision
We begin with an assessment, not an injection. During a consultation at our Beaconsfield clinic, we review your concerns, medical history, current skincare, previous aesthetic treatments and any history of sensitivity or pigmentation changes.
We also offer a free five to 15 minute photo consultation through WhatsApp for initial triage, pricing guidance and treatment direction. A photo consultation isn't a substitute for a full assessment, but it can help us decide whether an in-person appointment is appropriate.
What happens on treatment day
Your skin is cleansed and prepared before we use a topical numbing cream to improve comfort. Polynucleotides are then delivered through a series of precise injections into the areas selected during consultation, which may include the face or neck depending on your goals and suitability.
The experience can feel stingy, particularly in sensitive areas, but we manage comfort carefully. After treatment, we apply soothing aftercare and explain what to avoid while the skin settles.
The typical course is three sessions spaced two to four weeks apart, as described by Skin Revision's treatment information. Results are gradual, so we don't assess the final direction of treatment immediately after the first appointment.

Aftercare and recovery
Small raised injection points, mild swelling, tenderness or bruising can occur. These effects usually settle as the skin recovers, but the exact experience depends on the treated area, injection response and individual healing pattern.
We advise clients to follow the specific aftercare provided at their appointment. Avoid unnecessary touching, intense heat and strenuous activity immediately afterwards, and don't restart strong active skincare until we've advised that the skin is ready.
Bruising isn't exclusive to polynucleotides. Our guide to bruising after injectable treatments explains why it can happen and how we approach it responsibly. Contact us promptly if a reaction seems unusual, severe or is getting worse rather than improving.
Preparation matters: arrive with clean skin where possible, tell us about every relevant medication or supplement and plan your appointment around the possibility of temporary marks.
How Polynucleotides Compare with Other Injectable Treatments
A client with crepey skin, fine lines and reduced elasticity may not need added volume. Polynucleotides are designed to support regeneration, hydration and skin quality, so they occupy a different role from filler. Profhilo and traditional skin boosters focus more strongly on hydration and surface freshness, while microneedling uses controlled skin stimulation without an injectable product.
| Treatment | Primary Action | Results Timeline | Typical Course | Best For |
|---|---|---|---|---|
| Polynucleotides | Supports repair, hydration, elasticity and dermal health | Gradual improvement over weeks | Three sessions commonly recommended, spaced two to four weeks apart | Fine lines, crepey texture, reduced elasticity and overall skin quality |
| Profhilo | Hydration-focused injectable treatment | Progressive freshness and suppleness | Course and maintenance depend on assessment | Dehydrated skin and diffuse loss of firmness |
| Skin boosters | Delivers hydration-focused support into the skin | Often progressive, with hydration a central aim | Varies by product and plan | Dull, dry or dehydrated skin |
| Microneedling | Creates controlled micro-injury to stimulate renewal | Develops progressively through healing | A course may be advised according to concern | Texture, superficial scarring and selected signs of ageing |
Our Profhilo treatment guide explains when a hydration-led approach may suit someone whose main concern is dryness rather than broader regenerative support.
Treatment choice also depends on skin tone, sensitivity and tolerance of downtime. Darker skin tones can be more prone to post-inflammatory pigmentation after skin injury, while sensitive skin may react more noticeably to injections or active aftercare. A careful consultation should cover previous reactions, pigmentation history, the treated area and whether microneedling is appropriate. Polynucleotides are not automatically the safest option, but a measured plan can make their skin-quality focus useful when volume replacement is not the goal.
Cost changes the comparison. UK polynucleotide pricing ranges from about £175 per session in some chains to £300 to £850 in some London clinics, according to UK polynucleotide treatment cost guidance. With three sessions commonly recommended and maintenance every six to 12 months, total treatment can exceed £750 to £1,050 before maintenance. The decision is therefore clinical and financial, not just a choice between injectable brands.
Other injectable trends also require scrutiny. This clinical review on glutathione risks provides useful context on product provenance, safety and professional oversight.
What the Current Evidence Shows
The research supports cautious use, rather than the stronger promises sometimes attached to regenerative treatments. Reviews have reported improvements in skin quality, but the number of participants remains limited and study designs vary. Those findings are consistent with polynucleotides being a developing treatment for texture, elasticity and hydration, not a proven replacement for fillers or every other injectable option.
What remains uncertain
Evidence quality matters in consultation. Much of the published research consists of observational studies, case reports and small pilot studies, with relatively few large, high-quality randomised controlled trials. A 2024 review of polynucleotide evidence highlights this limitation and helps explain why positive results should not be presented as guaranteed outcomes.
Low-to-moderate evidence does not mean the treatment is ineffective. It means confidence in the size, duration and consistency of the benefit remains limited. It also makes direct comparisons with established treatments difficult. Client selection, injection technique, product quality and follow-up can all affect the result, so published findings do not automatically predict what one person will experience.
Safety claims need the same restraint. The available studies have not established permanent correction, superiority over alternatives or long-term outcomes for every skin type. Sensitive skin and darker skin tones deserve individual assessment because treatment-related inflammation may affect tolerance and pigmentation risk.
Information about how to use a reconstitution kit is not clinical guidance for injectable treatment. Polynucleotide procedures require appropriate products, training, assessment, governance and sterile technique.
At Skin Revision, the practical question is whether the evidence supports the client's goal, risk tolerance and treatment plan. A consultation should cover expected changes, possible adverse effects, alternatives and the limits of current research before proceeding.
Candidacy, Pricing and Booking Your Consultation
Polynucleotides may suit adults concerned with fine lines, early laxity, crepey texture, dullness or reduced skin resilience who prefer gradual, natural-looking change. They may also be considered for selected clients with acne scarring or darker skin tones, provided we assess pigment risk, sensitivity and barrier condition carefully.
Pricing varies across the UK. Some providers charge about £175 per session, while other clinics charge £300 to £850, and a course can exceed £750 to £1,050 before maintenance (UK pricing context for polynucleotide treatment). We'll discuss the likely course, alternatives and ongoing costs before treatment rather than presenting a single appointment price without context.
Skin Revision is based at 9a Burkes Parade, Station Road, Beaconsfield HP9 1NN. Jacqui Bannister and Sarra Kourdi provide consultation-led skin treatment for clients from Beaconsfield, Gerrards Cross, Amersham, High Wycombe, Marlow, Slough and the wider Buckinghamshire, Berkshire and Hertfordshire areas.
Book a consultation if you'd like us to assess whether polynucleotides, Profhilo, microneedling, LED therapy, AlumierMD skincare or another treatment is the most sensible route for your skin.
Skin Revision offers personalised consultations and polynucleotides skin treatment planning at our Beaconsfield clinic, with careful consideration for sensitive and darker skin tones. Visit Skin Revision to contact us, arrange your consultation and discuss a realistic treatment plan with our team.

